The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial

The intra-tumor stroma percentage in colon cancer (CC) patients has previously been reported by our group as a strong independent prognostic parameter. Patients with a high stroma percentage within the primary tumor have a poor prognosis. Tissue samples from the most invasive part of the primary tum...

Full description

Bibliographic Details

Published in:	Annals of oncology 2013-01, Vol.24 (1), p.179-185
Main Authors:	Huijbers, A., Tollenaar, R.A.E.M., v Pelt, G.W., Zeestraten, E.C.M., Dutton, S., McConkey, C.C., Domingo, E., Smit, V.T.H.B.M., Midgley, R., Warren, B.F., Johnstone, E.C., Kerr, D.J., Mesker, W.E.
Format:	Article
Language:	eng
Subjects:	Antineoplastic agents ASCO Biological and medical sciences colon cancer Colonic Neoplasms - pathology Double-Blind Method Gastroenterology. Liver. Pancreas. Abdomen Humans Medical sciences pathology Pharmacology. Drug treatments Prognosis prognostic Stomach. Duodenum. Small intestine. Colon. Rectum. Anus stroma Stromal Cells - pathology Survival Analysis Tumors VICTOR
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!